ROUTE90 Pivotal Study
Intersection of Research & Innovation
Route90 is a prospective, multi-center, pivotal study of Eye90® microspheres in unresectable hepatocelluar cancer. Click the image below to learn more about trial design and research data.
Latest News
April 8, 2026
ABK Biomedical and COR Development Partner to Establish Long-Term Commercial Manufacturing Facility in Ashland, Missouri
March 31, 2026
ABK Biomedical and MURR Forge Long-Term Partnership to Advance Breakthrough Cancer Therapy
February 24, 2026
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
Our Products
Eye90 microspheres®
A novel technology for Y90 radioembolization made with a proprietary, imageable glass composition for in-procedure visualization.
Easi-Vue™ embolic microspheres
Imageable bland embolization product allowing direct visualization at the target site. FDA 510(k) clearance for the embolization of arteriovenous malformations and hypervascular tumors.
The ABK Biomedical Team
We are dedicated to encouraging a stimulating work environment offering an opportunity to significantly expand experience and skills by researching, developing, and commercializing cutting-edge medical device technologies with a mandate to effectively treat cancer.
ABK Biomedical is an equal opportunity employer offering competitive compensation packages.
Business Partners
ABK Biomedical is proud to partner with cutting-edge organizations and individuals with exceptional skills, scientific expertise, and the highest business ethics.
Research Partners
Development Partners
ABK Biomedical is ISO Certified
Corporate Offices
Halifax Office (Main Office)
155 Chain Lake Drive
Unit 32
Halifax, NS B3S 1B3
Canada
T. 902.442.4009
Orange County Office
555 Corporate Drive
Suite 105
Ladera Ranch, CA, 92694
USA
ABK Biomedical Inc. provides and continues to provide accurate information on its website. However, ABK Biomedical Inc. assumes no responsibility for the accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. Furthermore, ABK Biomedical Inc. may change the products mentioned, and their stage in development, at any time without notice. ABK Biomedical Inc. is a clinical-stage company engaged in the research and development of new medical devices. Eye90 microspheres® is considered an investigational product and is NOT FDA-approved for use.
Copyright 2022 - All International Rights Reserved